← Back to directory

Patrick J. Loehrer

Researcher Next ID · RN-021789

Researcher · Medicine

Indiana University Health

Indianapolis, Kenya

Not currently recruitingFunding unknown
Works count
544
Citation count
26,424
H-index
81
i10-index
241

Research interests

Medicine
Myasthenia Gravis and Thymoma
Testicular diseases and treatments
Colorectal Cancer Treatments and Studies
Pituitary Gland Disorders and Treatments
Global Cancer Incidence and Screening

Publications

  • The Integrated Genomic Landscape of Thymic Epithelial Tumors

    Cancer Cell · 2018 · 10.1016/j.ccell.2018.01.003

  • Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

    The Lancet Oncology · 2015 · 10.1016/s1470-2045(14)71181-7

  • Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

    Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.32.9607

  • Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

    Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2011.34.8904

  • Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

    Yearbook of Oncology · 2008 · 10.1016/s1040-1741(08)79037-7

  • Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

    Journal of Clinical Oncology · 2008 · 10.1200/jco.2008.21.2134

  • Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

    Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2004.10.182

  • National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002

    Gastrointestinal Endoscopy · 2002 · 10.1016/s0016-5107(02)70351-9

  • Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma

    Journal of Clinical Oncology · 2000 · 10.1200/jco.2000.18.16.2972

  • Thymoma: State of the Art

    Journal of Clinical Oncology · 1999 · 10.1200/jco.1999.17.7.2280

  • Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer

    New England Journal of Medicine · 1998 · https://doi.org/10.1056/nejm199810083391504

  • Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.

    Journal of Clinical Oncology · 1998 · 10.1200/jco.1998.16.7.2500

  • Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.

    Journal of Clinical Oncology · 1998 · 10.1200/jco.1998.16.4.1287

  • Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

    Journal of Clinical Oncology · 1997 · https://doi.org/10.1200/jco.1997.15.7.2564

  • Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.

    Journal of Clinical Oncology · 1995 · 10.1200/jco.1995.13.2.470

  • Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group.

    Journal of Clinical Oncology · 1994 · 10.1200/jco.1994.12.11.2264

  • Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.

    Journal of Clinical Oncology · 1994 · 10.1200/jco.1994.12.6.1164

  • A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

    Journal of Clinical Oncology · 1992 · https://doi.org/10.1200/jco.1992.10.7.1066

  • Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.

    Journal of Clinical Oncology · 1991 · 10.1200/jco.1991.9.7.1163

  • Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

    Journal of Clinical Oncology · 1989 · 10.1200/jco.1989.7.7.932

  • Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.

    Journal of Clinical Oncology · 1989 · 10.1200/jco.1989.7.3.387

  • Salvage Therapy in Recurrent Germ Cell Cancer: Ifosfamide and Cisplatin plus Either Vinblastine or Etoposide

    Annals of Internal Medicine · 1988 · 10.7326/0003-4819-109-7-540

  • Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide

    New England Journal of Medicine · 1987 · 10.1056/nejm198706043162302

  • Cisplatin

    Annals of Internal Medicine · 1984 · 10.7326/0003-4819-100-5-704

  • The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases

    Cancer · 1984 · 10.1002/1097-0142(19841101)54:9<1824::aid-cncr2820540910>3.0.co;2-j

Current projects

    No projects listed.